Ardent Health Partners (NYSE:ARDT) Given "Overweight" Rating at Stephens

Stephens reiterated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT - Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. The firm currently has a $22.00 price objective on the stock.

Other research analysts also recently issued research reports about the stock. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Truist Financial dropped their price objective on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada lowered their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Tuesday, March 4th. Finally, Morgan Stanley dropped their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Ardent Health Partners presently has a consensus rating of "Buy" and a consensus target price of $21.18.

Remove Ads

Ardent Health Partners Price Performance

Shares of ARDT traded up $0.02 during trading hours on Wednesday, hitting $13.18. The stock had a trading volume of 338,692 shares, compared to its average volume of 404,640. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a 12 month low of $12.87 and a 12 month high of $20.72. The stock has a fifty day moving average price of $14.41 and a 200 day moving average price of $16.23.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. As a group, analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. acquired a new position in Ardent Health Partners in the fourth quarter valued at approximately $27,000. US Bancorp DE purchased a new stake in Ardent Health Partners in the fourth quarter valued at approximately $31,000. R Squared Ltd purchased a new position in shares of Ardent Health Partners during the fourth quarter worth $37,000. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners in the third quarter valued at $42,000. Finally, New York State Common Retirement Fund purchased a new stake in shares of Ardent Health Partners in the 4th quarter valued at $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.